Find out everything you need to know about us.

About Faberco

Faberco Life Sciences Inc. (FLS), a Philippine biopharmaceutical organization, is focused on providing innovative, highly niche pharmaceutical products to both public and private health sectors. Faberco partners with reputable international manufacturers who target product platforms and therapeutic categories to treat and prevent diseases which are of public health concern.

Pursuing a passion for excellence in operations and services ensures access to premium quality yet affordable products that meet national and international regulatory standards.

Our team consists of competent and experienced members with expertise in public health, market research, sales and distribution, medical affairs, financial and operational management.

The organization operates on an end-to-end ERP system, that includes an automated warehouse and logistics management system with the capacity to expand business growth and enable quick and efficient order fulfilment for customer satisfaction.

Our current product lines consist of the following therapeutic categories, Antiretroviral drugs (ARVs for HIV), Vaccines, Hormonal Contraceptives, Diagnostic Imaging, and Respiratory Care.

Future extensions will also include Neurology, Psychiatric and Substance Disorder, Addiction, Pain Management, Oncology and Immunosuppressive products, Critical Care products, Screening Tests

Our Genesis


A privately owned biopharmaceutical company, Faberco was established in 2017 for the purpose of sourcing, importing, distributing and marketing pharmaceutical products and medical equipment.


Faberco works closely with both private institutions and government entities to provide valued healthcare products for patients nationwide.


We focus on targeting niche markets and provide evaluation, registration, and market development of products for the Philippine Market.

Our Mission

To provide equitable and affordable access to life-saving, innovative, niche healthcare products for all, in partnership with reputable pharmaceutical companies who are the gold standard in patient-care.

Our Vision

Quality, Reliability, Transparency and Excellence is what we aim to be known for. We envision being able to contribute to protecting and improving people’s lives by facilitating access to niche treatment and preventive medicines at the maximum cost benefit for both public and private health sectors.

Our Commitment

We strongly believe in transparency, integrity and an uncompromising adherence to robust moral and ethical business principles and values. Faberco emphasizes on being a dependable and reputable partner in order to provide the best healthcare solutions to our partners. We are committed to the pursuit of excellence in product quality and to the provision of superior customer service. We promote and encourage continuous process improvements to ensure equitable value to all our partners.

Our Leadership

Meet our leaders who work with determination to address crucial public health needs.

Kishore Hemlani

Founding Member

Kishore Hemlani, as a founding member, serves as an adviser to Faberco Life Sciences Inc. He mentors the board and its organization in business strategies, research and development in the Public Health sector.

“Fueled by my passion in health and as an investor myself, I aim to make this company one of the leading providers of reliable, affordable, and cost-effective pharmaceutical products that are critical to the health of the Filipino people.” – Kishore Hemlani

Mr. Hemlani has founded and invested in businesses across various sectors such as in real estate, finance, and technology. He is committed to make the company grow and make a difference in Public Health by improving the quality of life.

Vinay Panemanglor

Founding Member and Chairman, Board of Directors

Mr. Panemanglor is a founding member of Faberco Life Sciences, and serves as its Chairman of the Board of Directors. Together with his co-founding member, Mr. Panemanglor has helped introduce targeted and crucial treatment options for HIV, and childhood vaccination, amongst others to the Philippines.

Providing healthcare options remains to be a major priority as he co-leads the organization in introducing targeted therapy for devastating diseases. Mr. Panemanglor has been in the pharmaceutical industry for over 30 years, and was a pioneer in opening up the Philippine market to generics, and branded generics, which have greatly helped provide equitable care across the country.

Mr. Panemanglor received an undergraduate degree in Chemistry, and a master’s degree in Business Administration.

"Choose Safety, Choose Quality, Choose Excellence"

Faberco Life Sciences